Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin
In today's Pharmaceutical Executive Daily, the FDA approves leucovorin as the first-ever treatment for an ultra-rare genetic condition called cerebra…
4 months ago
Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time
In today’s Pharmaceutical Executive Daily, Vinay Prasad exits the FDA’s Center for Biologics Evaluation and Research for the second time in under a y…
4 months ago
Pharmaceutical Executive Daily: Cognito Therapeutics and Nexcure Secure Financing Rounds
In today’s Pharmaceutical Executive Daily, Cognito Therapeutics and Nexcure secure new financing rounds to advance their pipelines, artificial intell…
4 months, 1 week ago
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
In today’s Pharmaceutical Executive Daily, Antengene and UCB enter a billion-dollar global licensing agreement for a bispecific T-cell engager, Teva …
4 months, 1 week ago
The Ongoing Impact of MFN Pricing
Alice Valdur Curan discusses how the industry continues to strategize around this complicated order.
4 months, 1 week ago
Pharmaceutical Executive Daily: Novo Nordisk Commits $506 Million to Ireland Manufacturing Site
In today’s Pharmaceutical Executive Daily, industry leaders examine how to measure AI’s return on investment across the life sciences value chain, No…
4 months, 1 week ago
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
In today’s Pharmaceutical Executive Daily, the FDA approves an expanded indication for Palynziq in patients aged 12 and older, Sogroya becomes the fi…
4 months, 1 week ago
Pharmaceutical Executive Daily: FDA Approves Hernexeos
In today’s Pharmaceutical Executive Daily, the FDA approves Hernexeos under a national priority voucher program, industry leaders explore the expansi…
4 months, 2 weeks ago
Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan
In today’s Pharmaceutical Executive Daily, Alkermes outlines its CEO succession plan following Richard Pops’ retirement announcement, leadership chan…
4 months, 2 weeks ago
The Ron Lanton Report: Is Healthcare Consolidation Reaching Its Limits?
The episode will explore structural implications for supply chains, distribution models, and international strategy, not a political discussion, but …
4 months, 2 weeks ago